Skip to main content
Intended for healthcare professionals
Restricted access
Research article
First published online November 18, 2017

Association of procalcitonin values and bacterial infections in pediatric patients receiving extracorporeal membrane oxygenation

Abstract

Objective:

There is increasing data in pediatrics demonstrating procalcitonin (PCT) is more sensitive and specific than other biomarkers in the setting of bacterial infections. However, the use of PCT in neonatal and pediatric extracorporeal membrane oxygenation (ECMO) is not well described. Therefore, the purpose of this study was to describe the clinical utility of PCT in determining the absence or presence of bacterial infections in neonatal and pediatric patients on ECMO.

Methods:

This was a retrospective electronic medical record (EMR) review of data between January 1, 2010 to June 30, 2016 at a single, free-standing, childrens hospital. All patients on ECMO with ≥1 PCT level obtained while receiving ECMO support were eligible for inclusion. The EMR was searched for chest radiographs (CXR) and bacterial culture results (urine, blood, cerebrospinal fluid (CSF), bronchoalveolar lavage (BAL) and respiratory cultures). All bacterial and viral cultures obtained within 5 days of PCT levels being obtained were analyzed. PCT levels of 0.5, 0.9, 1.0, 1.4 and 2.0 were used as the initial cut-off values for the analysis. The sensitivity, specificity, positive predictive value (PPV), negative predictive values (NPV) and likelihood ratios were calculated for each of the PCT levels.

Results:

Twenty-seven patients met the inclusion criteria and contributed 193 PCT values for the analysis. The median age was 8 months (range 0 days to 18 years). Linear regression analysis demonstrated that a PCT cut-off of 0.5, 0.9 and 1.4 predicted the presence of a bacterial infection. The PCT value with the most utility was 0.5, with a sensitivity of 92%, a specificity of 43%, a positive predictive value of 60% and a negative predictive value (NPV) of 86%.

Conclusion:

This is the largest data set evaluating PCT in neonatal and pediatric patients on ECMO. A PCT value of 0.5 ng/mL had the most utility for determining the absence or presence of a bacterial infection in the setting of ECMO with a high sensitivity and NPV.

Get full access to this article

View all access and purchase options for this article.

References

1. Gibbon J. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37: 171–185; passim.
2. Baffes TG, Fridman JL, Bicoff JP, et al. Extracorporeal circulation for support of palliative cardiac surgery in infants. Ann Thorac Surg 1970; 10: 354–363.
3. Bartlett RH, Gazzaniga AB, Jefferies MR, et al. Extracor-poreal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976; 22: 80–93.
4. Extracorporeal Life Support Organization. ELSO International Registry. https://www.elso.org/Registry/Statistics/InternationalSummary.aspx (March 2016, accessed March 28, 2016.
5. Simon L, Saint-Louis P, Amre DK, et al. Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome. Pediatr Crit Care Med 2008; 9: 407–413.
6. Rungatscher A, Merlini A, De Rita F, et al., Diagnosis of infection in paediatric veno-arterial cardiac extracorporeal membrane oxygenation: role of procalcitonin and C-reactive protein. Eur J Cardiothorac Surg 2013; 43: 1043–1049.
7. Agarwal S, Akba N, Soundar EP, et al., Validation of the procalcitonin (PCT) assay: experience in a pediatric hospital. Clin Biochem 2015; 48: 886–890.
8. Anand D, Das S, Bhargava S, et al., Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study. J Crit Care 2015; 30: 218.e7–12.
9. Becker KL, Nylen ES, White JC, et al. Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004; 89: 1512–1525.
10. Bizzarro MJ, Conrad SA, Kaufman DA, et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 2011; 12: 277–281.
11. Meyer D, Jessen ME, Eberhart RC. Neonatal extracoporeal membrane oxygenation complicated by sepsis. Ann Thorac Surg 1995; 59: 975–980.
12. Leclerc F, Cremer R, Noizet R. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children. Pediatr Crit Care Med 2003; 4: 264–266.
13. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323: 17–29.
14. Cies JJ, Chopra A. Procalcitonin use in a pediatric intensive care unit. Pediatr Infect Dis J 2014; 33: 984–986.
15. Pieri M, Greco T, De Bonis M, et al. Diagnosis of infection in patients undergoing extracorporeal membrane oxygenation: a case-control study. J Thorac Cardiovasc Surg 2012; 143: 1411–1416.
16. Tanaka D, Pitcher HT, Cavarocchi NC, et al. Can procalcitonin differentiate infection from systemic inflammatory reaction in patients on extracorporeal membrane oxygenation? J Heart Lung Transplant 2014; 33: 1186–1188.

Cite article

Cite article

Cite article

OR

Download to reference manager

If you have citation software installed, you can download article citation data to the citation manager of your choice

Share options

Share

Share this article

Share with email
EMAIL ARTICLE LINK
Share on social media

Share access to this article

Sharing links are not relevant where the article is open access and not available if you do not have a subscription.

For more information view the Sage Journals article sharing page.

Information, rights and permissions

Information

Published In

Article first published online: November 18, 2017
Issue published: May 2018

Keywords

  1. procalcitonin
  2. pediatric
  3. neonatal
  4. extracorporeal life support
  5. ECMO
  6. ECLS

Rights and permissions

© The Author(s) 2017.
Request permissions for this article.
PubMed: 29153041

Authors

Affiliations

Vi Ean Tan
St. Christopher’s Hospital for Children, Philadelphia, PA, USA
Drexel University College of Medicine, Philadelphia, PA, USA
Wayne S. Moore
The Center for Pediatric Pharmacotherapy, LLC, Pottstown, PA, USA
Arun Chopra
NYU Langone Medical Center, New York, NY, USA
NYU School of Medicine, New York, NY, USA
Jeffrey J. Cies
St. Christopher’s Hospital for Children, Philadelphia, PA, USA
Drexel University College of Medicine, Philadelphia, PA, USA
The Center for Pediatric Pharmacotherapy, LLC, Pottstown, PA, USA

Notes

Jeffrey J. Cies, Pharmacy Clinical Coordinator, Critical Care and Infectious Diseases Clinical Pharmacist, St. Christopher’s Hospital for Children, 160 East Erie Avenue, Philadelphia, PA 19134-1095, USA. Email: [email protected]

Metrics and citations

Metrics

Journals metrics

This article was published in Perfusion.

VIEW ALL JOURNAL METRICS

Article usage*

Total views and downloads: 414

*Article usage tracking started in December 2016


Altmetric

See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores



Articles citing this one

Receive email alerts when this article is cited

Web of Science: 8 view articles Opens in new tab

Crossref: 8

  1. Fever and Leukocytosis Are Poor Predictors of Bacterial Coinfection in...
    Go to citation Crossref Google Scholar
  2. Procalcitonin and Pediatric Traumatic Brain Injury: Differentiating Ne...
    Go to citation Crossref Google Scholar
  3. The utility of sepsis scores for predicting blood stream infections in...
    Go to citation Crossref Google ScholarPub Med
  4. Diagnostic Accuracy of Infection Markers to Diagnose Infections in Neo...
    Go to citation Crossref Google Scholar
  5. Risk Factors of Venoarterial Extracorporeal Membrane Oxygenation–Relat...
    Go to citation Crossref Google Scholar
  6. Nosocomial Infections During Extracorporeal Membrane Oxygenation in Ne...
    Go to citation Crossref Google Scholar
  7. Validation of the Procalcitonin Assay on the Abbott Architect i1000
    Go to citation Crossref Google Scholar
  8. Impact of continuous renal replacement therapy (CRRT) and other extrac...
    Go to citation Crossref Google Scholar

Figures and tables

Figures & Media

Tables

View Options

Get access

Access options

If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:


Alternatively, view purchase options below:

Purchase 24 hour online access to view and download content.

Access journal content via a DeepDyve subscription or find out more about this option.

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text